SCIENTIFIC BACKGROUND

CACNA1S, KCNJ2, SCN4A

Category:

Scientific Background

Autosomal dominant inherited primary periodic paralyses are characterized by reversible episodic muscle weakness and intermittent myotonia. Seizure-like paralyses regress within a few hours to a few days; respiratory muscles are less affected, and consciousness and speech are always unaffected. It is caused by dysfunction in the muscular ion channels (sodium, calcium, potassium channels) that control myocyte activity. Muscle weakness may be associated with changes in serum potassium levels, and it can be differentiated into hyperkalemic or hypokalemic periodic paralysis. However, a clinical differentiation based on serum potassium, which must be determined during the onset of symptoms, is not always possible.

 

The most common form is hypokalemic periodic paralysis (HypoPP), which has a prevalence of 1:100,000. The paralysis of all extremities, which lasts from one hour to days, is accompanied by a drop in serum potassium level below 3mmol/L (reference value: 3.5-5mmol/L). The severity of the paralysis can be highly variable: from mild weakness to complete paralysis of the extremities. The first symptoms usually appear before the age of 20, with a peak in seizure frequency between the ages of 15 and 35. The seizures can be triggered by factors including high-carbohydrate meals, stress, alcohol consumption, or physical exertion. In very severe cases, persistent weakness of the limb-girdle muscles may develop later during the course of the disease.

 

Pathogenic variants in the CACNA1S gene can be detected in approximately 60% of patients with HypoPP. This gene encodes the alpha-1 subunit of the muscular voltage-gated calcium channel CaV1.1 that is predominantly expressed in skeletal muscle and the retina. Variants in this gene are also associated with a predisposition to malignant hyperthermia. Pathogenic variants in the SCN4A gene are found in approximately 10% of HypoPP cases.

 

References

Fialho et al. 2018, Handb Clin Neurol 148:505 / Statland et al. 2018 Muscle Nerve 57:522 / Statland et al. 2013, Continuum (Minneap Minn) 19 (6 Muscle Disease):1598 / Matthews et al. 2010, J Physiol 588:1879 / Striessnig et al. 2010, Pflugers Arch 460:361 / Rayan & Hanna 2010, Curr Op in Neur 23:466

GENES

CACNA1S, KCNJ2, SCN4A

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more